Search

everythinglearnresearchcommunity

for

Search:↓

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A group has developed therapies that show promise for treating cancer and various other conditions.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The treatment is safe and shows promise for metastatic breast cancer.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Some chemotherapy can cause permanent hair loss.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Some patients' hair grew back black and white after chemotherapy.

More research is needed to understand chemotherapy-induced hair loss and its phases.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.